Probius

Quantum-inspired signal analysis for disease detection and drug discovery

Probius

Fund I

Fund

2024

Funded

Healthcare / Bioanalytics

Category
Visit website
More Info
Moving Bioanalysis from a Reagent-Centric to a Data-Centric Approach

Probius has developed QES, a bioanalytical platform that captures rich biochemical data and integrates it directly into AI workflows. By enabling faster diagnostics and decentralized processing, its system accelerates insights for healthcare and drug development.

Probius

 in the news

No items found.